Purchases and Sales Made in Q4 2024 in 4 D Molecular Therapeutics, Inc. (FDMT)
This table provides information about the institutional ownership of 4 D Molecular Therapeutics, Inc. (FDMT) during Q4 2024. The information is specifically focused on institutions that hold shares of 4D Molecular Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 10, 2025
Q4 2024
|
Intech Investment Management LLC
West Palm Beach, FL |
SELL
|
- |
-2.93K- 11.82% |
$15.5K - $30.5K
|
21.8K
$90.8K
|
|
Jan 31, 2025
Q4 2024
|
New York State Common Retirement Fund
|
SELL
|
- |
-3.1K- 19.82% |
$16.4K - $32.3K
|
12.5K
$52.2K
|
|
Feb 14, 2025
Q4 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-3.12K- 7.96% |
$16.5K - $32.4K
|
36K
$150K
|
|
Feb 14, 2025
Q4 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-3.99K- 13.06% |
$21.1K - $41.5K
|
26.5K
$110K
|
|
Feb 14, 2025
Q4 2024
|
State Of Wisconsin Investment Board
Madison, WI |
SELL
|
- |
-4.39K- 6.84% |
$23.2K - $45.6K
|
59.7K
$249K
|
|
Feb 14, 2025
Q4 2024
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
SELL
|
- |
-8.89K- 1.11% |
$47.1K - $92.6K
|
795K
$3.31M
|
|
Feb 13, 2025
Q4 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-9.6K- 8.36% |
$50.9K - $100K
|
105K
$438K
|
|
Feb 07, 2025
Q4 2024
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-20.9K- 55.54% |
$111K - $218K
|
16.7K
$69.7K
|
|
Feb 12, 2025
Q4 2024
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-24.4K- 2.35% |
$129K - $254K
|
1.01M
$4.21M
|
|
Feb 06, 2025
Q4 2024
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-29.7K- 8.78% |
$157K - $309K
|
309K
$1.28M
|
|
Feb 13, 2025
Q4 2024
|
Bank Of Montreal
Toronto, A6 |
SELL
|
- |
-31.4K- 58.85% |
$167K - $327K
|
22K
$91.4K
|
|
Feb 14, 2025
Q4 2024
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-36K- 10.71% |
$191K - $375K
|
300K
$1.25M
|
|
Feb 14, 2025
Q4 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-54.8K- 33.95% |
$290K - $570K
|
107K
$443K
|
|
Feb 14, 2025
Q4 2024
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-65.2K- 5.16% |
$345K - $679K
|
1.2M
$4.98M
|
|
Feb 13, 2025
Q4 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-76.9K- 36.8% |
$407K - $800K
|
132K
$549K
|
|
Feb 14, 2025
Q4 2024
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-106K- 36.59% |
$562K - $1.1M
|
184K
$765K
|
|
Feb 13, 2025
Q4 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-112K- 68.07% |
$596K - $1.17M
|
52.7K
$219K
|
|
Feb 14, 2025
Q4 2024
|
Ra Capital Management, L.P.
Boston, MA |
SELL
|
- |
-535K- 10.49% |
$2.84M - $5.57M
|
4.56M
$19M
|
|
Feb 14, 2025
Q4 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-561K- 69.87% |
$2.97M - $5.84M
|
242K
$1.01M
|
|
Feb 14, 2025
Q4 2024
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-885K- 28.21% |
$4.69M - $9.21M
|
2.25M
$9.37M
|
|
Jan 14, 2025
Q4 2024
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-890K- 57.66% |
$4.72M - $9.26M
|
654K
$2.72M
|
|
Feb 14, 2025
Q4 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-1M- 47.43% |
$5.32M - $10.4M
|
1.11M
$4.63M
|
|
Feb 14, 2025
Q4 2024
|
Vr Adviser, LLC
New York, NY |
SELL
|
- |
-1.45M- 32.9% |
$7.67M - $15.1M
|
2.95M
$12.3M
|
|
Feb 14, 2025
Q4 2024
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-3.49M- 85.11% |
$18.5M - $36.3M
|
610K
$2.54M
|
|
Feb 14, 2025
Q4 2024
|
Bvf Inc
San Francisco, CA |
SELL
|
- |
-4.71M- 63.83% |
$25M - $49.1M
|
2.67M
$11.1M
|